Surprising dietary findings show Japanese patients with psoriasis had higher BMI, lower intake of meat, and higher intake of seafood, sugar/sweeteners, vitamin D and vitamin B12, challenging long-held nutritional beliefs.
Patients and providers agreed that Skindex instruments are important complements to patient global assessments for determining disease burden and severity in clinical practice.
Use of cyclosporine, infliximab, and anti-IL17 agents may be associated with increased risk of symptomatic urinary tract infection in women with psoriasis.
A clinical guideline for the use of phototherapy for the care and management of adult patients with psoriasis developed by the American Academy of Dermatology (AAD) and National Psoriasis Foundation (NPF) has been published.
Type, rather than number, of comorbidities, has a greater effect on the quality of life of patients with psoriatic arthritis, according to recent research.
A fixed-dose combination lotion comprised of halobetasol propionate 0.01% and tazarotene 0.045% (HP/TAZ) is more effective for treating moderate-to-severe plaque psoriasis than either component alone.
Researchers completed 2 post hoc analyses of large, double-blind trials examining the efficacy of HP/TAZ combination therapy for clinically meaningful outcomes.
The extracutaneous manifestations of psoriasis and guidance on use of biologic treatment for management of psoriasis are discussed in 2 new guidelines.
The final analysis set comprised biologic-naïve individuals — individuals who had filled an initial prescription for etanercept, infliximab, adalimumab, or ustekinumab after 2 years without using any biologic agent during the study period.
